Cme Group INC Form 4 insider transactions

CME Group Inc. Director Charles P. Carey reported the sale of 500 shares of Class A Common Stock for approximately $132,676.50 on June 10, 2025, as part of a Rule 10b5-1 plan.

CME Group Director Daniel G. Kaye reported the sale of 500 shares of Common Stock Class A at a price of $282.4193 per share on May 22, 2025, reducing his direct beneficial ownership to 3,668 shares, as part of a pre-scheduled Rule 10b5-1 plan.

Jonathan L. Marcus, Sr MD General Counsel of CME Group Inc., sold 390 shares of Common Stock Class A at $277.5 per share on May 20, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Phyllis M. Lockett, a director of CME Group Inc., sold 1,060 shares of Class A common stock on May 19, 2025, at a weighted average price of $277.88 per share.

Director Martin J. Gepsman sold 300 shares of CME Group Inc. common stock at a price of $273.17 on May 15, 2025.

Charles P. Carey, a director of CME Group Inc., sold 3,000 shares of Class A common stock on May 15, 2025, at a weighted average price of $272.56.

Derek Sammann, a Senior Managing Director at CME Group, reported the acquisition and disposal of CME Group Class A common stock through direct and indirect ownership.

Derek Sammann, Senior Managing Director at CME Group, amends his Form 4 to reflect changes in beneficial ownership following a performance share award and a transfer of stock to a revocable living trust.

Director Dennis Suskind sold 1,000 shares of CME Group Class A common stock at an average price of $271.28 on April 29, 2025.

Director Larry Gerdes sold a total of 4,000 shares of CME Group Class A common stock in late April 2025.

William Shepard, a director at CME Group, increased his holdings of Class A Common Stock through a dividend reinvestment plan.

William Shepard, a director at CME Group, amended his Form 4 filing to reflect an updated number of shares acquired through a dividend reinvestment plan.

Director Deborah J. Lucas sold 1,500 shares of CME Group Inc. stock at a price of $256.95 on March 14, 2025.

CME Group's Chief Transformation Officer, Ken Vroman, reports acquisition of shares from a performance share award and subsequent surrender of shares to cover tax obligations.

Timothy McCourt, a Senior Managing Director at CME Group, reports acquiring and disposing of Class A Common Stock on March 15, 2025, related to performance share awards and tax obligations.

Sunil Cutinho, Chief Information Officer of CME Group, reports the acquisition of shares from a performance share award and the surrender of shares for tax obligations.

Terrence Duffy, Chairman and CEO of CME Group, reports acquiring shares from a performance share award and disposing of shares to cover tax obligations.

Hilda Harris Piell, Sr MD & Chief HR Officer at CME Group, reports acquisition of shares from a performance share award and subsequent surrender of shares to cover tax obligations.

Derek Sammann, Senior Managing Director and Global Head of Commodities Markets at CME Group, reports acquisition and disposal of company stock related to a performance share award.

Suzanne Sprague, COO & Global Head of Clearing at CME Group, reports acquisition and disposal of company stock to satisfy tax obligations related to performance share awards.

Jonathan L. Marcus, Sr MD General Counsel of CME Group Inc., surrendered 269 shares of Common Stock Class A on March 15, 2025, to cover tax obligations upon vesting of restricted stock.

Julie Winkler, Sr MD Chief Commercial Officer of CME Group, reports acquisition of 3,668 shares and disposition of 1,625 shares for tax obligations related to a performance share award.

Lynne Fitzpatrick, President and CFO of CME Group, reports acquisition and disposal of company stock to cover tax obligations and vesting of performance share awards.

Jack J. Tobin, MD Chief Accounting Officer of CME Group Inc., reports acquisition and disposal of company stock related to a performance share award.

Director Howard J. Siegel sold 10,000 shares of CME Group Inc. at $260 per share on March 13, 2025.

CME Group's Chairman and CEO, Terrence A. Duffy, sold 30,000 shares of Class A common stock on March 11, 2025, at an average price of $259.18.

Suzanne Sprague, COO & Global Head of Clearing at CME Group, sold 1,500 shares of Common Stock Class A on March 3, 2025, at a price of $256.8329 per share.

Jack J. Tobin, MD Chief Accounting Officer of CME Group Inc., reported a gift of 43 shares of Common Stock Class A to his adult children on February 27, 2025, resulting in a decrease in his direct holdings.

Hilda Harris Piell, Sr MD & Chief HR Officer of CME Group Inc., sold 3,984 shares of Common Stock Class A on February 27, 2025, at a price of $250.465 per share.

Ken Vroman, Chief Transformation Officer of CME Group Inc., reported the sale of 5,066 shares of Common Stock Class A on February 13, 2025.